Literature DB >> 33001876

CDC Deployments to State, Tribal, Local, and Territorial Health Departments for COVID-19 Emergency Public Health Response - United States, January 21-July 25, 2020.

Emilio Dirlikov, Ethan Fechter-Leggett, Stacy L Thorne, Caitlin M Worrell, Jennifer C Smith-Grant, Jonathan Chang, Alexandra M Oster, Adam Bjork, Stanley Young, Alvina U Perez, Tricia Aden, Mark Anderson, Susan Farrall, Jaime Jones-Wormley, Katherine Hendricks Walters, Tanya T LeBlanc, Rebecca Greco Kone, David Hunter, Laura A Cooley, Vikram Krishnasamy, Jennifer Fuld, Carolina Luna-Pinto, Tanya Williams, Ann O'Connor, Randall J Nett, Julie Villanueva, Nadia L Oussayef, Henry T Walke, Jill M Shugart, Margaret A Honein, Dale A Rose.   

Abstract

Coronavirus disease 2019 (COVID-19) is a viral respiratory illness caused by SARS-CoV-2. During January 21-July 25, 2020, in response to official requests for assistance with COVID-19 emergency public health response activities, CDC deployed 208 teams to assist 55 state, tribal, local, and territorial health departments. CDC deployment data were analyzed to summarize activities by deployed CDC teams in assisting state, tribal, local, and territorial health departments to identify and implement measures to contain SARS-CoV-2 transmission (1). Deployed teams assisted with the investigation of transmission in high-risk congregate settings, such as long-term care facilities (53 deployments; 26% of total), food processing facilities (24; 12%), correctional facilities (12; 6%), and settings that provide services to persons experiencing homelessness (10; 5%). Among the 208 deployed teams, 178 (85%) provided assistance to state health departments, 12 (6%) to tribal health departments, 10 (5%) to local health departments, and eight (4%) to territorial health departments. CDC collaborations with health departments have strengthened local capacity and provided outbreak response support. Collaborations focused attention on health equity issues among disproportionately affected populations (e.g., racial and ethnic minority populations, essential frontline workers, and persons experiencing homelessness) and through a place-based focus (e.g., persons living in rural or frontier areas). These collaborations also facilitated enhanced characterization of COVID-19 epidemiology, directly contributing to CDC data-informed guidance, including guidance for serial testing as a containment strategy in high-risk congregate settings, targeted interventions and prevention efforts among workers at food processing facilities, and social distancing.

Entities:  

Mesh:

Year:  2020        PMID: 33001876      PMCID: PMC7537553          DOI: 10.15585/mmwr.mm6939a3

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


Coronavirus disease 2019 (COVID-19) is a viral respiratory illness caused by SARS-CoV-2. During January 21–July 25, 2020, in response to official requests for assistance with COVID-19 emergency public health response activities, CDC deployed 208 teams to assist 55 state, tribal, local, and territorial health departments. CDC deployment data were analyzed to summarize activities by deployed CDC teams in assisting state, tribal, local, and territorial health departments to identify and implement measures to contain SARS-CoV-2 transmission (). Deployed teams assisted with the investigation of transmission in high-risk congregate settings, such as long-term care facilities (53 deployments; 26% of total), food processing facilities (24; 12%), correctional facilities (12; 6%), and settings that provide services to persons experiencing homelessness (10; 5%). Among the 208 deployed teams, 178 (85%) provided assistance to state health departments, 12 (6%) to tribal health departments, 10 (5%) to local health departments, and eight (4%) to territorial health departments. CDC collaborations with health departments have strengthened local capacity and provided outbreak response support. Collaborations focused attention on health equity issues among disproportionately affected populations (e.g., racial and ethnic minority populations, essential frontline workers, and persons experiencing homelessness) and through a place-based focus (e.g., persons living in rural or frontier areas). These collaborations also facilitated enhanced characterization of COVID-19 epidemiology, directly contributing to CDC data-informed guidance, including guidance for serial testing as a containment strategy in high-risk congregate settings, targeted interventions and prevention efforts among workers at food processing facilities, and social distancing.

CDC Deployments to Assist Health Departments

On January 21, 2020, CDC activated its Emergency Operations Center to facilitate coordination for domestic and international COVID-19 response efforts (); the same day, at the request of the Washington State Health Department, CDC deployed a team to Washington to support the health department’s epidemiologic investigation of the first U.S. case of COVID-19 in a traveler returning from China (). On March 15, CDC established a dedicated COVID-19 response section to support state, tribal, local, and territorial health departments (). CDC deployment data were analyzed to describe activities by deployed CDC teams in assisting state, tribal, local, and territorial health departments in the identification and implementation of measures to contain SARS-CoV-2 transmission (). The CDC COVID-19 state, tribal, local, and territorial response section provides support to health departments by responding to inquiries, identifying and collaborating with CDC subject matter experts, and deploying CDC teams in response to receipt of official requests for assistance from health departments. Dedicated teams of CDC subject matter experts have participated in evaluating contact tracing efforts and have investigated COVID-19 epidemiology in counties with rapidly increasing numbers of cases and incidence (“hotspots”) to identify jurisdictions needing targeted support (). Further, the CDC COVID-19 state, tribal, local, and territorial response section helps coordinate efforts between CDC, health departments, and subject matter experts across federal agencies and other organizations including the CDC Foundation, the National Association of County and City Health Officials, the Association of Public Health Laboratories, Association of State and Territorial Health Officials, and the Council of State and Territorial Epidemiologists. The CDC COVID-19 state, tribal, local, and territorial response section coordinated deployment requirements with health departments and selected staff members with the necessary skills after an official request for assistance. CDC COVID-19 Response General Staff, Division of Emergency Operations, and Office of Safety, Security, and Asset Management ensured that all deployers were supported before, during, and after deployment, including providing briefings before and after deployments; coordinating risk assessments, medical clearance, and travel and lodging arrangements; and issuing deployment-essential equipment, including personal protective equipment to prevent SARS-CoV-2 transmission during field deployments. Deployer feedback received during postdeployment debriefings were used to improve deployment processes and procedures for subsequent deployments. During January 21–July 25, in response to official requests for assistance, 1,009 CDC staff members participated in 208 CDC deployment teams to assist 55 state, tribal, local, and territorial health departments with COVID-19 emergency public health response activities (Figure 1)*; some persons deployed multiple times. Trends in the deployment of CDC teams generally followed trends in national COVID-19 case counts. The number of deployed field teams per week increased during January–April and declined during May–June; however, from mid-June to July 25, the number of deployed teams increased (Figure 2).
FIGURE 1

Location of deployments* by CDC staff members to state, tribal, local, and territorial health departments — United States, January 21–July 25, 2020

Abbreviations: DC = District of Columbia; NMI = Northern Mariana Islands; PR = Puerto Rico; USVI = U.S. Virgin Islands.

* 726 CDC staff members deployed on 208 teams, as part of 1,009 total deployments (individual staff members could deploy more than one time).

FIGURE 2

Number of CDC deployment teams to state, tribal, local, and territorial health departments and reported COVID-19 cases, by week — United States, week 4–30 (N = 208 teams)*

Abbreviation: COVID-19 = coronavirus disease 2019.

* Does not include deployments to U.S. quarantine stations and airports, repatriations centers, as part of outbreak response on cruise ships, or other response teams.

Location of deployments* by CDC staff members to state, tribal, local, and territorial health departments — United States, January 21–July 25, 2020 Abbreviations: DC = District of Columbia; NMI = Northern Mariana Islands; PR = Puerto Rico; USVI = U.S. Virgin Islands. * 726 CDC staff members deployed on 208 teams, as part of 1,009 total deployments (individual staff members could deploy more than one time). Number of CDC deployment teams to state, tribal, local, and territorial health departments and reported COVID-19 cases, by week — United States, week 4–30 (N = 208 teams)* Abbreviation: COVID-19 = coronavirus disease 2019. * Does not include deployments to U.S. quarantine stations and airports, repatriations centers, as part of outbreak response on cruise ships, or other response teams. Among 168 (81%) teams that had completed deployment by July 25, the mean deployment duration was 20 days (range 1–89 days) (Table). Among the remaining 40 teams deployed as of July 25, duration of deployment ranged from 1–146 days; several teams were providing sustained epidemiologic support. Among the 208 teams deployed following official requests for assistance, 178 (85%) provided assistance to state health departments, 12 (6%) to tribal health departments, 10 (5%) to local health departments, and eight (4%) to territorial health departments.
TABLE

Summary of CDC deployment teams* and staff members to state, tribal, local, and territorial health departments for COVID-19 emergency public health response — United States, January 21–July 25, 2020

CharacteristicNo. (%)
Total teams
208 (100)
Team deployment duration, mean days (range)
Completed deployment (168 teams)
20 (1–89)
Currently deployed as of July 25 (40 teams)
48 (1–146)
Teams by jurisdiction type
State
178 (85)
Tribal
12 (6)
Local
10 (5)
Territorial
8 (4)
Teams by types of technical assistance provided
Epidemiology
144 (69)
Infection prevention and control in health care settings
77 (37)
Health communications
37 (18)
Community mitigation
36 (17)
Occupational safety and health
31 (15)
Laboratory
21 (10)
Surge support
9 (4)
Information technology
8 (4)
Teams that assisted with investigating transmission in high-risk congregate settings
Total§
87 (42)
Long-term care facilities
53 (26)
Food processing facilities
24 (12)
Correctional facilities
12 (6)
Settings that provide services to persons experiencing homelessness
10 (5)
Deployed staff members*
Total individual deployments
1,009
Total individual CDC staff members who deployed
726
No. of times individual staff members deployed
1
516 (71)
2
156 (21)
3
40 (6)
4
9 (1)
5
5 (1)
Primary deployer role among total individual deployments
Epidemiologic support
422 (42)
Leadership**
137 (14)
Infection prevention and control
88 (9)
Clinical support††
65 (6)
Data science
59 (6)
Laboratory science
47 (5)
Health communications and community outreach
46 (5)
Subject matter expertise§§
36 (4)
Occupational safety and health
31 (3)
Coordination
28 (3)
Veterinary science
11 (1)
Behavioral science
12 (1)
Other¶¶27 (3)

Abbreviation: COVID-19 = coronavirus disease 2019.

* Deployments through CDC COVID-19 health department response section. Does not include deployments to U.S. quarantine stations and airports, repatriations centers, as part of outbreak response on cruise ships, or other response teams. Some individual CDC staff members were deployed more than once.

† Deployed teams provided a diversity of technical assistance, and a single team could assist with more than one area of technical assistance.

§ Total differs from sum of all high-risk congregate settings because some teams worked in multiple high-risk congregate settings.

¶ Percent represents percentage of total CDC staff members who deployed.

** Leadership includes staff members with any deployment roles listed as “Senior,” “Lead,” “Deputy,” “Team Lead,” “Co-Lead,” or “Deputy Lead,” with leadership staff member classification superseding all other classifications.

†† Clinical support includes staff members who were physicians, nurses, or pharmacists who were not listed with an alternate primary deployer role.

§§ Subject matter expertise includes staff members with any deployment roles listed as “SME,” “Specialist,” and deployments under COVID-19 Resource Assistance Field Team and Centers for Medicare & Medicaid Services teams.

¶¶ Other includes staff members listed as vessel sanitation, technical assistance, focus groups, and individual deployments that could not otherwise be classified (n = 23).

Abbreviation: COVID-19 = coronavirus disease 2019. * Deployments through CDC COVID-19 health department response section. Does not include deployments to U.S. quarantine stations and airports, repatriations centers, as part of outbreak response on cruise ships, or other response teams. Some individual CDC staff members were deployed more than once. † Deployed teams provided a diversity of technical assistance, and a single team could assist with more than one area of technical assistance. § Total differs from sum of all high-risk congregate settings because some teams worked in multiple high-risk congregate settings. ¶ Percent represents percentage of total CDC staff members who deployed. ** Leadership includes staff members with any deployment roles listed as “Senior,” “Lead,” “Deputy,” “Team Lead,” “Co-Lead,” or “Deputy Lead,” with leadership staff member classification superseding all other classifications. †† Clinical support includes staff members who were physicians, nurses, or pharmacists who were not listed with an alternate primary deployer role. §§ Subject matter expertise includes staff members with any deployment roles listed as “SME,” “Specialist,” and deployments under COVID-19 Resource Assistance Field Team and Centers for Medicare & Medicaid Services teams. ¶¶ Other includes staff members listed as vessel sanitation, technical assistance, focus groups, and individual deployments that could not otherwise be classified (n = 23). Because state, tribal, local, and territorial health departments could request assistance with a range of public health activities, deployed team members possessed diverse technical skills and expertise, and a single team could provide technical assistance in multiple areas. The top five areas of technical assistance provided by deployed teams were the following: 1) epidemiologic support (144 teams; 69%), 2) infection prevention and control in health care settings (77; 37%), 3) health communications (37; 18%), 4) community mitigation (36; 17%), and 5) occupational safety and health (31; 15%). Some deployed CDC teams provided subject matter expertise in investigation and mitigation of SARS-CoV-2 transmission in high-risk congregate settings, which often include populations at increased risk for severe COVID-19–associated outcomes, such as long-term care facilities (53 teams; 26%), food processing facilities (24 teams; 12%), correctional facilities (12; 6%), and settings that provide services to persons experiencing homelessness (10; 5%). Knowledge, attitudes, and practices surveys helped involve community members in identifying barriers to services, difficulties experienced when trying to follow prevention actions, and preferred communication channels. Aligned with CDC’s COVID-19 health equity strategy, some teams focused attention on supporting local officials in describing health equity issues, such as describing SARS-CoV-2 transmission among disproportionately affected racial and ethnic minority populations, essential frontline workers, persons experiencing homelessness, as well as through a place-based focus, such as responding to COVID-19 outbreaks in rural communities and frontier areas. Twenty-eight (13%) teams deployed specifically to assist in addressing SARS-CoV-2 transmission among racial and ethnic minority groups, including supporting tribal health departments and those focused on COVID-19 among migrant farm workers. Because CDC staff members could deploy more than once, the 1,009 CDC staff member deployments included 726 individual CDC staff members. Overall, 516 (71%) staff members deployed once, 156 (21%) deployed twice, and 54 (8%) deployed three or more times. Among the 1,009 individual deployments, the top four primary deployer roles were epidemiologic support (422; 42%), leadership (137; 14%), infection prevention and control (88; 9%), and clinical support (65; 6%); additional primary deployer roles included data science, laboratory science, health communications and community outreach, occupational safety and health, coordination, veterinary science, and behavioral science. Deployed CDC staff members helped increase local capacity by assisting with developing data collection instruments, conducting trainings on COVID-19 case investigation and contact tracing, and providing support to improve public health information technology systems.

Discussion

CDC continues to respond to official requests for assistance from state, tribal, local, and territorial health departments toward supporting COVID-19 emergency public health response activities, including through the deployment of CDC staff members. CDC deployments were responsive to evolving public health needs, as reflected by similar trends in number of deployed teams and reported national case counts. Approximately 700 CDC staff members deployed, and approximately one half of individual deployments were completed by staff members who had deployed more than once. On average, teams deployed for nearly 3 weeks, and several teams provided more sustained support. Collaborations between health departments and CDC have provided critical information for developing new or revised national guidance including improved mitigation strategies (https://www.cdc.gov/coronavirus/2019-ncov/communication/guidance-list.html). For example, CDC and health departments developed and implemented the use of serial testing as a successful containment strategy, which was used to interrupt transmission in long-term care facilities in Washington (), in correctional and detention facilities in Louisiana (), and among residents and staff members of homeless shelters in Washington** (). Multijurisdictional support helped describe the need for targeted interventions and prevention efforts among workers at food processing facilities, including an analysis of COVID-19 cases among meat and poultry processing facility workers in 23 states that found that among cases with race/ethnicity reported, 87% occurred among racial or ethnic minorities (). More generally, deployed teams assisted health departments conduct epidemiologic investigation after outbreaks associated with social gatherings, such as cases and deaths resulting from transmission at two family gatherings in Chicago (); the results of these investigations helped support and refine CDC COVID-19 recommendations on social distancing. The impact of collaborations extends beyond health agencies. For example, on April 2, the Centers for Medicare & Medicaid Services and CDC issued guidance to implement universal testing of long-term care facility residents, covered through Medicare, as an effective containment strategy, based on collaborative work between CDC and health departments, including in King County, Washington (). On July 30, Tyson Foods, the world’s second largest processor of chicken, beef, and pork, announced it would expand weekly COVID-19 testing and symptom monitoring among employees as part of a nationwide strategy to contain infections, per CDC guidance and after data analysis conducted in collaboration with 23 state health departments (). Among 90 total COVID-19–related reports published in MMWR up to the August 28th issue, 30 (33%) resulted from these deployments. The findings in this report are subject to at least two limitations. First, deployment data could be subject to data quality issues, despite regular data reviews and a full review of individual deployment data for this report. Second, this report describes deployments through the CDC COVID-19 state, tribal, local, and territorial response section. Health departments were also supported by other CDC COVID-19 response sections, as well as by CDC staff members already working within state, tribal, local, and territorial departments of health, such as Career Epidemiology Field Officers, Public Health Associates,*** and Epidemic Intelligence Service Officers. In addition, during January 17–July 25, 2020, CDC deployed 513 staff members to U.S. quarantine stations and airports as well as 159 staff members to support repatriation missions. As the COVID-19 pandemic continues, ongoing collaboration between health departments and CDC will aim to strengthen local capacity, assist with outbreak response, and, as new evidence emerges, directly contribute to data-informed guidance that will benefit local and national response efforts.

What is already known about this topic?

As part of the COVID-19 emergency public health response, CDC deploys field teams upon request to assist state, tribal, local, and territorial health departments.

What is added by this report?

As of July 25, 2020, CDC had deployed 208 teams to assist 55 state, tribal, local, and territorial health departments. Teams worked with local counterparts to address transmission in high-risk settings, including long-term care facilities (26%), food processing facilities (12%), correctional facilities (6%), and settings providing services to persons experiencing homelessness (5%).

What are the implications for public health practice?

CDC collaborations with health departments have strengthened local capacity, assisted with outbreak response, and directly contributed to data-informed guidance, benefiting local and national response efforts.
  10 in total

1.  Updated preparedness and response framework for influenza pandemics.

Authors:  Rachel Holloway; Sonja A Rasmussen; Stephanie Zaza; Nancy J Cox; Daniel B Jernigan
Journal:  MMWR Recomm Rep       Date:  2014-09-26

2.  Initial Public Health Response and Interim Clinical Guidance for the 2019 Novel Coronavirus Outbreak - United States, December 31, 2019-February 4, 2020.

Authors:  Anita Patel; Daniel B Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-02-07       Impact factor: 17.586

3.  COVID-19 Outbreak Among Three Affiliated Homeless Service Sites - King County, Washington, 2020.

Authors:  Farrell A Tobolowsky; Elysia Gonzales; Julie L Self; Carol Y Rao; Ryan Keating; Grace E Marx; Temet M McMichael; Margaret D Lukoff; Jeffrey S Duchin; Karin Huster; Jody Rauch; Hedda McLendon; Matthew Hanson; Dave Nichols; Sargis Pogosjans; Meaghan Fagalde; Jennifer Lenahan; Emily Maier; Holly Whitney; Nancy Sugg; Helen Chu; Julia Rogers; Emily Mosites; Meagan Kay
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-05-01       Impact factor: 17.586

4.  First Case of 2019 Novel Coronavirus in the United States.

Authors:  Michelle L Holshue; Chas DeBolt; Scott Lindquist; Kathy H Lofy; John Wiesman; Hollianne Bruce; Christopher Spitters; Keith Ericson; Sara Wilkerson; Ahmet Tural; George Diaz; Amanda Cohn; LeAnne Fox; Anita Patel; Susan I Gerber; Lindsay Kim; Suxiang Tong; Xiaoyan Lu; Steve Lindstrom; Mark A Pallansch; William C Weldon; Holly M Biggs; Timothy M Uyeki; Satish K Pillai
Journal:  N Engl J Med       Date:  2020-01-31       Impact factor: 91.245

5.  Serial Laboratory Testing for SARS-CoV-2 Infection Among Incarcerated and Detained Persons in a Correctional and Detention Facility - Louisiana, April-May 2020.

Authors:  Henry Njuguna; Megan Wallace; Sean Simonson; Farrell A Tobolowsky; Allison E James; Keith Bordelon; Rena Fukunaga; Jeremy A W Gold; Jonathan Wortham; Theresa Sokol; Danielle Haydel; Ha Tran; Kaylee Kim; Kiva A Fisher; Mariel Marlow; Jacqueline E Tate; Reena H Doshi; Kathryn G Curran
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-07-03       Impact factor: 17.586

6.  Update: COVID-19 Among Workers in Meat and Poultry Processing Facilities - United States, April-May 2020.

Authors:  Michelle A Waltenburg; Tristan Victoroff; Charles E Rose; Marilee Butterfield; Rachel H Jervis; Kristen M Fedak; Julie A Gabel; Amanda Feldpausch; Eileen M Dunne; Connie Austin; Farah S Ahmed; Sheri Tubach; Charles Rhea; Anna Krueger; David A Crum; Johanna Vostok; Michael J Moore; George Turabelidze; Derry Stover; Matthew Donahue; Karen Edge; Bernadette Gutierrez; Kelly E Kline; Nichole Martz; James C Rajotte; Ernest Julian; Abdoulaye Diedhiou; Rachel Radcliffe; Joshua L Clayton; Dustin Ortbahn; Jason Cummins; Bree Barbeau; Julia Murphy; Brandy Darby; Nicholas R Graff; Tia K H Dostal; Ian W Pray; Courtney Tillman; Michelle M Dittrich; Gail Burns-Grant; Sooji Lee; Alisa Spieckerman; Kashif Iqbal; Sean M Griffing; Alicia Lawson; Hugh M Mainzer; Andreea E Bealle; Erika Edding; Kathryn E Arnold; Tomas Rodriguez; Sarah Merkle; Kristen Pettrone; Karen Schlanger; Kristin LaBar; Kate Hendricks; Arielle Lasry; Vikram Krishnasamy; Henry T Walke; Dale A Rose; Margaret A Honein
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-07-10       Impact factor: 17.586

7.  Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020.

Authors:  Anne Kimball; Kelly M Hatfield; Melissa Arons; Allison James; Joanne Taylor; Kevin Spicer; Ana C Bardossy; Lisa P Oakley; Sukarma Tanwar; Zeshan Chisty; Jeneita M Bell; Mark Methner; Josh Harney; Jesica R Jacobs; Christina M Carlson; Heather P McLaughlin; Nimalie Stone; Shauna Clark; Claire Brostrom-Smith; Libby C Page; Meagan Kay; James Lewis; Denny Russell; Brian Hiatt; Jessica Gant; Jeffrey S Duchin; Thomas A Clark; Margaret A Honein; Sujan C Reddy; John A Jernigan
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-03       Impact factor: 17.586

8.  Public Health Response to the Initiation and Spread of Pandemic COVID-19 in the United States, February 24-April 21, 2020.

Authors:  Anne Schuchat
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-05-08       Impact factor: 17.586

9.  Trends in Number and Distribution of COVID-19 Hotspot Counties - United States, March 8-July 15, 2020.

Authors:  Alexandra M Oster; Gloria J Kang; Amy E Cha; Vladislav Beresovsky; Charles E Rose; Gabriel Rainisch; Laura Porter; Eduardo E Valverde; Elisha B Peterson; Anne K Driscoll; Tina Norris; Nana Wilson; Matthew Ritchey; Henry T Walke; Dale A Rose; Nadia L Oussayef; Monica E Parise; Zack S Moore; Aaron T Fleischauer; Margaret A Honein; Emilio Dirlikov; Julie Villanueva
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-08-21       Impact factor: 17.586

10.  Community Transmission of SARS-CoV-2 at Two Family Gatherings - Chicago, Illinois, February-March 2020.

Authors:  Isaac Ghinai; Susan Woods; Kathleen A Ritger; Tristan D McPherson; Stephanie R Black; Laura Sparrow; Marielle J Fricchione; Janna L Kerins; Massimo Pacilli; Peter S Ruestow; M Allison Arwady; Suzanne F Beavers; Daniel C Payne; Hannah L Kirking; Jennifer E Layden
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2020-04-17       Impact factor: 17.586

  10 in total
  4 in total

1.  The impact of the COVID-19 pandemic on negative symptoms in individuals at clinical high-risk for psychosis and outpatients with chronic schizophrenia.

Authors:  Gregory P Strauss; Kelsey I Macdonald; Ivan Ruiz; Ian M Raugh; Lisa A Bartolomeo; Sydney H James
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-04-21       Impact factor: 5.270

Review 2.  SARS-CoV-2 and Variant Diagnostic Testing Approaches in the United States.

Authors:  Emmanuel Thomas; Stephanie Delabat; Yamina L Carattini; David M Andrews
Journal:  Viruses       Date:  2021-12-13       Impact factor: 5.048

Review 3.  Miller Fisher syndrome associated with COVID-19: an up-to-date systematic review.

Authors:  Zheng Li; Xingye Li; Jianxiong Shen; Matthew T V Chan; William Ka Kei Wu
Journal:  Environ Sci Pollut Res Int       Date:  2021-03-06       Impact factor: 4.223

Review 4.  Diagnostic Testing for SARS-CoV-2 Infection.

Authors:  Emmanuel Thomas; Stephanie Delabat; David M Andrews
Journal:  Curr Hepatol Rep       Date:  2021-10-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.